Project Number 3R01AG049702-02S2 Agency/Funding Organization NIA Funding Year 2017 View Full Project Details for Phase 1 clinical studies with the gamma-secretase modulator, NGP 555 to establish safety, pharmacokinetics, and biomarker efficacy Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) a. Amyloid beta Researcher and Organization Principal Investigator KOUNNAS, MARIA ZOE Principal Investigator First Name MARIA Principal Investigator Last Name KOUNNAS Awardee Organization NEUROGENETIC PHARMACEUTICALS, INC. Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PA-14-077: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp) FY Overall Cost $136,920 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M
